2017 - Calprotectin

NICE releases Medtech Innovation Briefing on calprotectin point of care and home testing for monitoring IBD treatment.

Healthcare Professionals, NewsBy Webmaster December 13, 2017

On 4th December 2017 the National Institute for Health and Care Excellence issued a Medtech Innovation Briefing [MIB132]: ‘Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease’. This describes the innovative aspect that test results can be acted on more quickly than waiting for standard laboratory tests and could help reduce colonoscopies and clinical appointments. Costs may…

Bringing Calprotectin Testing In-house on the Abbott Architect C8000

fCAL turboBy Webmaster December 11, 2017

Mary O’Connell née Deasy, Biochemistry Department Mercy University Hospital Cork, Ireland describes her experience introducing the BÜHLMANN fCAL turbo assay onto her department’s Abbott Architect C8000. At the Biochemistry Department at Mercy University Hospital (MUH) in Cork we had been sending samples for faecal calprotectin testing away to a referral laboratory for analysis. This referral laboratory…

Launch of IBD Toolkit for GPs

Healthcare Professionals, NewsBy Webmaster November 28, 2017

The RCGP, in partnership with Crohn’s and Colitis UK, has launched an IBD toolkit for GPs and healthcare professionals. Clinical Champion for Inflammatory Bowel Disease, Dr Kevin Barrett, developed the toolkit with the patient representative Rachel Fowler and the project’s steering group. He comments “Inflammatory Bowel Disease affects at least 1 in 250 of the…

Expanded Range of Instruments with CE Marked Protocols for BÜHLMANN fCAL® turbo assay

Healthcare Professionals, NewsBy Webmaster September 22, 2017

BÜHLMANN application specialist Christina Gabris has recently visited the UK to validate some new instrument protocols for the fCAL turbo assay. Christina spent time in hospitals around Newcastle to optimise CE marked protocols for the Beckman AU5800 and AU680. The range of instruments with CE marked protocols for fCAL turbo has now been expanded to 28 including: Roche: cobas c501 & c502, cobas c701…

Introducing in-house Calprotectin Testing Directly on the Roche cobas® c702

fCAL turboBy Webmaster July 6, 2017

Turbo Charged from the Start Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN fCAL® turbo assay. Faecal calprotectin testing is used to help exclude inflammatory bowel disease (IBD) in patients with lower gastrointestinal symptoms. This is extremely useful, as most patients with…

City Hospital Triemli Optimizes Laboratory Workflow For Calprotectin Testing

fCAL turboBy Webmaster May 26, 2017

Interview with Anita Grünauer (BMA), Dr. Jasmin Barman-Aksözen (Head of Department Chemistry), and Predrag Nesic (Head of Department BMA Chemistry), Institute for Laboratory Medicine, City Hospital Triemli, Zurich …the BÜHLMANN fCAL® turbo assay eased our routine work in the laboratory tremendously and improved our service for senders: the results are reliable and match the clinical…

Children’s Hospital of Zurich introduces fCAL turbo on the Beckman UniCel DxC 600

fCAL turboBy Webmaster April 21, 2017

Interview with Mara Barbieru Deputy Senior Biomedical Analyst, Department of Clinical Chemistry and Biochemistry, Children’s Hospital of Zurich “For years, we had wanted to run Calprotectin in-house and now finally we can offer this.” Evaluating fCAL turbo – Beckman UniCel DxC 600 Mrs. Barbieru, the new calprotectin assay BÜHLMANN fCAL® turbo yields calprotectin results in random access mode within 10 minutes, on…

Bioanalytica Lucerne 2: BÜHLMANN fCAL® turbo evaluation on the Roche cobas® c501

fCAL turboBy Webmaster April 21, 2017

Interview with Yvonne Schallberger, Bioanalytica Lucerne 2. BÜHLMANN fCAL turbo Evaluation “By introducing BÜHLMANN fCAL® turbo we can finally provide the service the gastroenterologists of the St. Anna Hospital longed for, as well as improving the service of calprotectin determination for the resident doctors. Concerning the lab work, the introduction of the BÜHLMANN fCAL® turbo…

BÜHLMANN fCAL® turbo Faecal Calprotectin Assay Proves Consistent between Multiple Analysers

fCAL turbo, ReportsBy Webmaster March 3, 2017

There has been much interest in the BÜHLMANN fCAL turbo faecal calprotectin assay since its UK launch in early 2016. With the increasing demand for faecal calprotectin tests there is a growing need for such a flexible, random access, high throughput assay that can be performed on clinical chemistry platforms. Clinicians need to be able to…

Meeting the Demands for Increasing Faecal Calprotectin Tests

Healthcare Professionals, NewsBy Webmaster March 3, 2017

Labs are receiving increasing faecal calprotectin tests requests since NICE published Diagnostic Guideline 11: ‘Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’. This recommends faecal calprotectin as a first-line test for patients presenting with gastrointestinal (GI) symptoms indicative of IBS or IBD. Pam Bowe, team manager in the Department of Biochemistry at the Cumberland Infirmary, describes the evolution of her laboratory procedures to cope…